Answers are grounded in this paper and cite their sources.
We would like to report on a patient, a 52-year-old man with acute neurologic disorder, Guillain Barré Syndrome. He was successfully treated by intravenous immunoglobulin. The patient suffered from acute extensive anterior MI. 2 weeks after thrombolytic therapy with streptokinase, he developed GBS. Bangladesh Journal of Neuroscience 2017; Vol. 33 (2): 103-104
No takes yet. Share an insight, caveat, or question.
Uddin et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: